PM
ORGO icon

Prosight Management’s Organogenesis Holdings ORGO Stock Holding History

Prosight Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,000
Closed -$541K – 49
2021
Q3 		$541K Buy
38,000
+12,900
+51% +$200K 0.3% 40
2021
Q2 		$417K Buy
25,100
+9,868
+65% +$184K 0.26% 44
2021
Q1 		$278K Sell
15,232
-2,008,209
-99% -$27.2M 0.23% 36
2020
Q4 		$15.2M Buy
2,023,441
+1,346,888
+199% +$6.4M 7.04% 2
2020
Q3 		$2.6M Buy
676,553
+140,937
+26% +$557K 1.24% 28
2020
Q2 		$2.06M Sell
535,616
-136,659
-20% -$493K 0.88% 30
2020
Q1 		$2.17M Buy
672,275
+54,439
+9% +$233K 1.01% 26
2019
Q4 		$2.97M Buy
+617,836
New +$3.92M 1.3% 21

Other funds holding ORGO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prosight Management's ORGO Position: Q4 2021 in Review

Prosight Management sold out of Organogenesis Holdings (ORGO) in Q4 2021, closing a stake of 38,000 shares — an estimated $541K sold.

Prosight Management first reported a position in ORGO in Q4 2019 and held it in 8 quarters. The position peaked at $15.2M in Q4 2020. 157 funds tracked by Wall St. Rank hold ORGO as of Q4 2021.

  • Prosight Management reported no remaining Organogenesis Holdings position as of Q4 2021 after selling out during the quarter.
  • Prosight Management sold 38,000 Organogenesis Holdings shares in Q4 2021, an estimated $541K.
  • Prosight Management first reported a position in Organogenesis Holdings in Q4 2019 and held it in 8 quarters.
  • Prosight Management's Organogenesis Holdings position peaked at $15.2M in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2021.

Based on Prosight Management's 13F filing for Q4 2021, filed 14 Feb 2022.